<DOC>
	<DOCNO>NCT00626210</DOCNO>
	<brief_summary>Modafinil , trade name Provigil , medication approve Food Drug Administration treatment narcolepsy , obstructive sleep apnea/hypopnea syndrome , shift work sleep disorder . Each problem characterize difficulty sleep night excessive daytime sleepiness . Modafinil prescribe day counteract sleepiness . The idea behind treatment sleepiness lead napping day prevents patient tire sleepy enough get good sleep night . This study design determine medication `` reset '' participant ' sleep/wake rhythm normal rhythm .</brief_summary>
	<brief_title>Modafinil Treatment Sleep/Wake Disturbances Older Adults</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>A clinical diagnosis Alzheimer 's disease Mild Cognitive Impairment Subjective complaint sleep disruption , unsatisfactory sleep , early morning awakening , early bedtime , excessive daytime sleepiness . Such complaint make either potential participant caregiver . Participation clinical drug trial Liver failure Believed investigator unwilling unable follow protocol Active liver coronary disease</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Mild Cognitive Impairment ( MCI )</keyword>
	<keyword>Sleep</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Memory</keyword>
</DOC>